University of Wisconsin Madison:製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C5155)
◆英語タイトル:University of Wisconsin Madison - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5155
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年9月
◆ページ数:52
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥73,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥109,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, business, engineering, graduate school, law school, nursing, veterinary medicine, public affairs, medicine and public health and library and information studies, among others. It also organizes youth programs such as Badger summer sports camps, PEOPLE Program, Saturday Enrichment, and Summer Science Institute. The institution’s research centers include Agribusiness Institute, Antarctic Meteorological Research Center, Aquatic Sciences Center, Biotechnology Center, Cardiovascular Research Center and Environmental Remote Sensing Center, among others. UW-Madison is headquartered in Madison, Wisconsin, the US.

University of Wisconsin Madison – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Wisconsin Madison, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Wisconsin Madison, Medical Devices Deals, 2012 to YTD 2018 10
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
FluGen Raises USD12 Million in Series A Financing 13
Madison Vaccines Raises Additional USD2 Million in Series A Financing 14
Madison Vaccines Raises US$8 Million In Series A Financing 15
Partnerships 17
Revive Therapeutics Enters into Research Agreement with University of Wisconsin Madison 17
NanoViricides Expands into Agreement with University of Wisconsin-Madison 18
Janssen Pharma Enters into Agreement with University of Wisconsin-Madison 19
Morphotek Enters into Research Agreement with University of Wisconsin Madison 20
UW Institute for Clinical and Translational Research to Form Partnership with German Center for Neurodegenerative Diseases 21
Licensing Agreements 22
Cellectar Biosciences Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 22
AhR Pharma Enters Into Licensing Agreement With WARF For Cancer Fighting Hormone 23
Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 24
AllCells Enters Into Licensing Agreement With Wisconsin Alumni Research Foundation And WiCell Research Institute 26
Equity Offering 27
Co-D Therapeutics Spin Off from University of Wisconsin Madison 27
University of Wisconsin Madison – Key Competitors 28
University of Wisconsin Madison – Key Employees 29
University of Wisconsin Madison – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Government and Public Interest 31
Jul 30, 2018: Researchers trace Parkinson’s damage in the heart 31
Jul 02, 2018: Study: Zika could cause more miscarriages than we realize 33
Jul 02, 2018: Zika may cause many more miscarriages than previously recognized 34
Jun 18, 2018: Researchers Uncover New Target to Stop Cancer Growth 35
May 08, 2018: Metastasis enablers: Findings could unlock new ovarian cancer treatments 36
Apr 24, 2018: Bacteria boost antifungal drug resistance in severe childhood tooth decay 38
Jan 23, 2018: Damon Runyon Cancer Research Foundation awards $3M to eleven innovative early career scientists 40
Jan 16, 2018: Study advances gene therapy for glaucoma 43
Oct 23, 2017: New study shows how cells can be led down non-cancer path 45
Aug 10, 2017: New measure of insulin-making cells could gauge diabetes progression, treatment 46
Jul 14, 2017: Advance furthers stem cells for use in drug discovery, cell therapy 47
Jun 27, 2017: Morgridge scientists illuminate structures vital to virus replication 48
Product News 50
Jan 24, 2017: Watching gene editing at work to develop precision therapies 50
Other Significant Developments 51
Jun 27, 2018: LGR6+ Cells And Defensin Peptides Deliver A New, Targeted Avenue For Treating Skin Aging 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Key Facts 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Wisconsin Madison, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Wisconsin Madison, Deals By Therapy Area, 2012 to YTD 2018 9
University of Wisconsin Madison, Medical Devices Deals, 2012 to YTD 2018 10
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
FluGen Raises USD12 Million in Series A Financing 13
Madison Vaccines Raises Additional USD2 Million in Series A Financing 14
Madison Vaccines Raises US$8 Million In Series A Financing 15
Revive Therapeutics Enters into Research Agreement with University of Wisconsin Madison 17
NanoViricides Expands into Agreement with University of Wisconsin-Madison 18
Janssen Pharma Enters into Agreement with University of Wisconsin-Madison 19
Morphotek Enters into Research Agreement with University of Wisconsin Madison 20
UW Institute for Clinical and Translational Research to Form Partnership with German Center for Neurodegenerative Diseases 21
Cellectar Biosciences Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 22
AhR Pharma Enters Into Licensing Agreement With WARF For Cancer Fighting Hormone 23
Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 24
AllCells Enters Into Licensing Agreement With Wisconsin Alumni Research Foundation And WiCell Research Institute 26
Co-D Therapeutics Spin Off from University of Wisconsin Madison 27
University of Wisconsin Madison, Key Competitors 28
University of Wisconsin Madison, Key Employees 29
University of Wisconsin Madison, Subsidiaries 30

List of Figures
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Wisconsin Madison, Medical Devices Deals, 2012 to YTD 2018 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ University of Wisconsin Madison:製薬・医療:M&Aディール及び事業提携情報(University of Wisconsin Madison - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆